-
Signature
-
/s/ Allison Blais, as attorney-in-fact
-
Issuer symbol
-
ADBE
-
Transactions as of
-
15 Sep 2023
-
Net transactions value
-
-$274,446
-
Form type
-
4
-
Filing time
-
19 Sep 2023, 18:18:40 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+62 |
+1.5% |
$0.000000 |
4,117 |
15 Sep 2023 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
$15,867 |
-30 |
-0.73% |
$528.89 |
4,087 |
15 Sep 2023 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+459 |
+11% |
$0.000000 |
4,546 |
15 Sep 2023 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
$120,058 |
-227 |
-5% |
$528.89 |
4,319 |
15 Sep 2023 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Sale |
$138,521 |
-264 |
-6.1% |
$524.70 |
4,055 |
18 Sep 2023 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-62 |
-14% |
$0.000000 |
372 |
15 Sep 2023 |
Common Stock |
62 |
$0.000000 |
Direct |
F3 |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-459 |
-14% |
$0.000000 |
2,750 |
15 Sep 2023 |
Common Stock |
459 |
$0.000000 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: